Effects of 2-deoxy-D-glucose on insulin-secretory responses to intravenous glucose, glucagon, tolbutamide and arginine in man.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000378:metabolism; D000328:Adult; D000818:Animals; D001120:Arginine / Q000494:pharmacology*; D001786:Blood Glucose; D003920:Diabetes Mellitus / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D005934:Glucagon / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D008297:Male; D012636:Secretory Rate; D013268:Stimulation, Chemical; D013552:Swine; D014044:Tolbutamide / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D001786:Blood Glucose; D007328:Insulin; D005934:Glucagon; D001120:Arginine; D014044:Tolbutamide; D000262:Adenylyl Cyclases; D005947:Glucose; D004837:Epinephrine